<?xml version="1.0" encoding="UTF-8"?>
<TEI xml:space="preserve" xmlns="http://www.tei-c.org/ns/1.0" 
xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" 
xsi:schemaLocation="http://www.tei-c.org/ns/1.0 https://raw.githubusercontent.com/kermitt2/grobid/master/grobid-home/schemas/xsd/Grobid.xsd"
 xmlns:xlink="http://www.w3.org/1999/xlink">
	<teiHeader xml:lang="en">
		<fileDesc>
			<titleStmt>
				<title level="a" type="main">Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases</title>
			</titleStmt>
			<publicationStmt>
				<publisher/>
				<availability status="unknown"><licence/></availability>
			</publicationStmt>
			<sourceDesc>
				<biblStruct>
					<analytic>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Dirk</forename><surname>Holzinger</surname></persName>
						</author>
						<author>
							<persName><roleName>MSc</roleName><forename type="first">Selina</forename><forename type="middle">Kathleen</forename><surname>Fassl</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Wilco</forename><surname>De Jager</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Peter</forename><surname>Lohse</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Ute</forename><forename type="middle">F</forename><surname>R€ Ohrig</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Marco</forename><surname>Gattorno</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">2nd Division of Pediatrics &apos;&apos;G. Gaslini&apos;&apos; Scientific Institute</orgName>
								<address>
									<settlement>Genoa</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Alessia</forename><surname>Omenetti</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">2nd Division of Pediatrics &apos;&apos;G. Gaslini&apos;&apos; Scientific Institute</orgName>
								<address>
									<settlement>Genoa</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sabrina</forename><surname>Chiesa</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">2nd Division of Pediatrics &apos;&apos;G. Gaslini&apos;&apos; Scientific Institute</orgName>
								<address>
									<settlement>Genoa</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Francesca</forename><surname>Schena</surname></persName>
							<affiliation key="aff3">
								<orgName type="department">2nd Division of Pediatrics &apos;&apos;G. Gaslini&apos;&apos; Scientific Institute</orgName>
								<address>
									<settlement>Genoa</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Judith</forename><surname>Austermann</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Thomas</forename><surname>Vogl</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Douglas</forename><forename type="middle">B</forename><surname>Kuhns</surname></persName>
							<affiliation key="aff4">
								<orgName type="department">Leidos Biomedical Research</orgName>
								<orgName type="institution">National Institute of Allergy and Infectious Diseases</orgName>
								<address>
									<settlement>Frederick</settlement>
								</address>
							</affiliation>
							<affiliation key="aff5">
								<orgName type="department" key="dep1">Department of Immunology</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="institution" key="instit1">National Insti-tutes of Health</orgName>
								<orgName type="institution" key="instit2">Hospital Universitario Son Espases</orgName>
								<address>
									<settlement>Palma de Mallorca</settlement>
								</address>
							</affiliation>
							<affiliation key="aff6">
								<orgName type="department">Department of Immunology-CDB</orgName>
								<orgName type="institution">Hospital Universitario de Canarias</orgName>
								<address>
									<settlement>La Laguna</settlement>
								</address>
							</affiliation>
							<affiliation key="aff7">
								<orgName type="department">Department of Paediatrics</orgName>
								<orgName type="institution">Hospital Clinic-IDIBAPS</orgName>
								<address>
									<settlement>Barce-lona</settlement>
								</address>
							</affiliation>
							<affiliation key="aff8">
								<orgName type="department" key="dep1">Department</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics</orgName>
								<orgName type="institution">Complejo Hospitalario Universitario Insular Materno Infantil of Pediatric Rheuma-tology Hospital Universitario Reina Sofia</orgName>
								<address>
									<addrLine>Las Palmas de Gran Canaria</addrLine>
									<settlement>Cordoba</settlement>
								</address>
							</affiliation>
							<affiliation key="aff9">
								<orgName type="department">ATTIKON&apos;&apos; Hospital</orgName>
								<orgName type="institution">Athens University Medical School</orgName>
								<address>
									<settlement>Athens</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Steven</forename><forename type="middle">M</forename><surname>Holland</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD</roleName><forename type="first">Carlos</forename><surname>Rodr Iguez-Gallego</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ricardo</forename><surname>L Opez-Almaraz</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Juan</forename><forename type="middle">I</forename><surname>Arostegui</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Elena</forename><surname>Colino</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Rosa</forename><surname>Roldan</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Smaragdi</forename><surname>Fessatou</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Bertrand</forename><surname>Isidor</surname></persName>
							<affiliation key="aff10">
								<orgName type="laboratory">Service de G en etique M edicale</orgName>
								<orgName type="institution">Centre Hospitalo-Universitaire</orgName>
								<address>
									<settlement>Nantes</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Sylvaine</forename><surname>Poignant</surname></persName>
							<affiliation key="aff11">
								<orgName type="department" key="dep1">Service de P ediatrie</orgName>
								<orgName type="department" key="dep2">Department of Pediatrics and Neonatology</orgName>
								<orgName type="department" key="dep3">Graduate School of Medical Sciences</orgName>
								<orgName type="department" key="dep4">Department of Gastroenterology, Infectious Diseases and Rheumatology</orgName>
								<orgName type="department" key="dep5">Department of Pediatrics</orgName>
								<orgName type="institution">Nagoya City University</orgName>
								<address>
									<addrLine>Campus Benjamin Franklin</addrLine>
									<settlement>Cholet, Cholet, Charit e-Universit€ atsmedizin Berlin, Berlin</settlement>
									<region>CH</region>
								</address>
							</affiliation>
							<affiliation key="aff12">
								<orgName type="department" key="dep1">Department of Pediatrics at</orgName>
								<orgName type="department" key="dep2">Division of Clinical Immunology and Allergy</orgName>
								<orgName type="institution" key="instit1">Stanford University School of Medicine</orgName>
								<orgName type="institution" key="instit2">University of California</orgName>
								<address>
									<settlement>San Francisco</settlement>
								</address>
							</affiliation>
							<affiliation key="aff13">
								<orgName type="department" key="dep1">Department of Pediatrics</orgName>
								<orgName type="department" key="dep2">Keck School of Medicine</orgName>
								<orgName type="institution" key="instit1">Children&apos;s Hospital Los Angeles</orgName>
								<orgName type="institution" key="instit2">University of Southern Cal-ifornia</orgName>
								<address>
									<settlement>Los Angeles</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Koichi</forename><surname>Ito</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Hans-Joerg</forename><surname>Epple</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jonathan</forename><forename type="middle">A</forename><surname>Bernstein</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Michael</forename><surname>Jeng</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jennifer</forename><surname>Frankovich</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Geraldina</forename><surname>Lionetti</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Joseph</forename><forename type="middle">A</forename><surname>Church</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Peck</forename><forename type="middle">Y</forename><surname>Ong</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Mona</forename><surname>Laplant</surname></persName>
							<affiliation key="aff14">
								<orgName type="institution">Children&apos;s Hospital and Clinics of Minnesota</orgName>
								<address>
									<settlement>Saint Paul</settlement>
								</address>
							</affiliation>
							<affiliation key="aff15">
								<orgName type="department">Department of Paediatric Immunology and Children&apos;s BMT Unit</orgName>
								<orgName type="institution">Great North Chil-dren&apos;s Hospital</orgName>
								<address>
									<settlement>Newcastle upon Tyne</settlement>
								</address>
							</affiliation>
							<affiliation key="aff16">
								<orgName type="department">Institute of Clinical Medicine</orgName>
								<orgName type="institution">Newcastle University</orgName>
								<address>
									<settlement>Newcastle upon Tyne</settlement>
								</address>
							</affiliation>
							<affiliation key="aff17">
								<orgName type="department">Department of Paediatric and Adolescent Haematology and Oncology and Children&apos;s BMT Unit</orgName>
								<orgName type="institution" key="instit1">Great North Children&apos;s Hospital</orgName>
								<orgName type="institution" key="instit2">Royal Victoria Infirmary</orgName>
								<address>
									<settlement>Newcastle upon Tyne</settlement>
								</address>
							</affiliation>
							<affiliation key="aff18">
								<orgName type="laboratory">bb the Human Dendritic Cell Laboratory</orgName>
								<orgName type="institution" key="instit1">Northern Institute of Cancer Research</orgName>
								<orgName type="institution" key="instit2">University of Newcastle</orgName>
								<address>
									<settlement>Newcastle upon Tyne</settlement>
								</address>
							</affiliation>
							<affiliation key="aff19">
								<orgName type="department">Institute for Clinical Immunology and Transfusion Medicine</orgName>
								<orgName type="institution">Newcastle University Medical School</orgName>
								<address>
									<settlement>Newcastle upon Tyne</settlement>
								</address>
							</affiliation>
							<affiliation key="aff20">
								<orgName type="institution">Justus Liebig University</orgName>
								<address>
									<settlement>Giessen</settlement>
								</address>
							</affiliation>
							<affiliation key="aff21">
								<orgName type="department">Department of Paediatrics/Paediatric Rheumatology</orgName>
								<orgName type="institution">dd Deutsches Zentrum f€ ur Kinder-und Jugendrheumatologie</orgName>
								<address>
									<settlement>Garmisch-Partenkirchen</settlement>
								</address>
							</affiliation>
							<affiliation key="aff22">
								<orgName type="department">Depart-ment of Dermatology</orgName>
								<orgName type="institution" key="instit1">St Maartenskliniek and Radboud University Nijmegen Medical Centre</orgName>
								<orgName type="institution" key="instit2">University Hospital Muenster</orgName>
								<orgName type="institution" key="instit3">National Human Genome Research Institute</orgName>
								<orgName type="institution" key="instit4">National Institutes of Health</orgName>
								<address>
									<settlement>Bethesda</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Mario</forename><surname>Abinun</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Rod</forename><surname>Skinner</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Venetia</forename><surname>Bigley</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ulrich</forename><forename type="middle">J</forename><surname>Sachs</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD, cc</roleName><forename type="first">Claas</forename><surname>Hinze</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, ee</roleName><forename type="first">Esther</forename><surname>Hoppenreijs</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Jan</forename><surname>Ehrchen</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Dirk</forename><surname>Foell</surname></persName>
						</author>
						<author>
							<persName><roleName>PhD, gg</roleName><forename type="first">Jae</forename><forename type="middle">Jin</forename><surname>Chae</surname></persName>
						</author>
						<author>
							<persName><roleName>MD, gg</roleName><forename type="first">Amanda</forename><surname>Ombrello</surname></persName>
						</author>
						<author>
							<persName><roleName>MD</roleName><forename type="first">Ivona</forename><surname>Aksentijevich</surname></persName>
						</author>
						<author role="corresp">
							<persName><roleName>MD</roleName><forename type="first">Johannes</forename><surname>Roth</surname></persName>
							<email>rothj@uni-muenster.de.</email>
						</author>
						<author>
							<affiliation key="aff0">
								<orgName type="department" key="dep1">Garmisch-Partenkirchen</orgName>
								<orgName type="department" key="dep2">Utrecht and Nijmegen</orgName>
								<orgName type="institution">Frederick and Bethesda</orgName>
								<address>
									<addrLine>The Netherlands, Palma de Mallorca</addrLine>
									<settlement>Muenster, Munich, Berlin, Giessen, Germany, Lausanne, Genoa, Md, La Laguna, Barcelona, Cordoba, Athens</settlement>
									<country>Switzerland, Italy, Spain, Greece</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff1">
								<orgName type="institution">Nantes and Cholet</orgName>
								<address>
									<addrLine>San Francisco, and Los Angeles</addrLine>
									<settlement>Nagoya, Calif, Saint Paul, Minn, and Newcastle upon Tyne</settlement>
									<region>Stanford</region>
									<country>France, Japan, United Kingdom</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff2">
								<orgName type="department" key="dep1">Institute of Immunology</orgName>
								<orgName type="department" key="dep2">Interdisciplinary Centre for Clinical Research IZKF</orgName>
								<orgName type="department" key="dep3">Department of Paediatric Rheumatology and Immunology</orgName>
								<orgName type="department" key="dep4">Department of Paediatric Immunology</orgName>
								<orgName type="department" key="dep5">Department of Clinical Chemistry Großhadern</orgName>
								<orgName type="department" key="dep6">Molecular Modeling Group</orgName>
								<orgName type="laboratory">Laboratory for Translational Immu-nology</orgName>
								<orgName type="institution" key="instit1">University of Muenster</orgName>
								<orgName type="institution" key="instit2">University Hospital Muenster</orgName>
								<orgName type="institution" key="instit3">University of Muenster</orgName>
								<orgName type="institution" key="instit4">University Children&apos;s Hospital Muenster</orgName>
								<orgName type="institution" key="instit5">University of Muenster</orgName>
								<orgName type="institution" key="instit6">University Medical Centre Utrecht</orgName>
								<orgName type="institution" key="instit7">University of Munich</orgName>
								<orgName type="institution" key="instit8">Swiss Institute of Bioinformatics</orgName>
								<address>
									<settlement>Lausanne</settlement>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff23">
								<orgName type="department">hh the Department for Translational Dermatoinfectiology</orgName>
								<orgName type="institution">University Hospital Muenster</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff24">
								<orgName type="department" key="dep1">Division of Intramural Research</orgName>
								<orgName type="department" key="dep2">Department of Health and Haman Services (to S.M.H</orgName>
								<orgName type="institution" key="instit1">National Institute of Allergy and Infectious Diseases</orgName>
								<orgName type="institution" key="instit2">National Instituters of Health</orgName>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff25">
								<orgName type="department">Institute of Immunology</orgName>
								<orgName type="institution">University of Muenster</orgName>
								<address>
									<postCode>48149</postCode>
									<settlement>Muenster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<author>
							<affiliation key="aff26">
								<orgName type="institution">University of Muenster</orgName>
								<address>
									<settlement>Muenster</settlement>
									<country key="DE">Germany</country>
								</address>
							</affiliation>
						</author>
						<title level="a" type="main">Single amino acid charge switch defines clinically distinct proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1)-associated inflammatory diseases</title>
					</analytic>
					<monogr>
						<imprint>
							<date/>
						</imprint>
					</monogr>
					<idno type="MD5">C4712DF13AD7A8CC14C2F9E31357F3B3</idno>
					<idno type="DOI">10.1016/j.jaci.2015.04.016</idno>
					<note type="submission">Received for publication February 10, 2014; revised February 13, 2015; accepted for publication April 8, 2015. Available online May 27, 2015.</note>
				</biblStruct>
			</sourceDesc>
		</fileDesc>
		<encodingDesc>
			<appInfo>
				<application version="0.7.2-SNAPSHOT" ident="GROBID" when="2022-05-18T11:45+0000">
					<desc>GROBID - A machine learning software for extracting information from scholarly documents</desc>
					<ref target="https://github.com/kermitt2/grobid"/>
				</application>
			</appInfo>
		</encodingDesc>
		<profileDesc>
			<abstract>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>Background: Hyperzincemia and hypercalprotectinemia (Hz/Hc) is a distinct autoinflammatory entity involving extremely high serum concentrations of the proinflammatory alarmin myeloid-related protein (MRP) 8/14 (S100A8/S100A9 and calprotectin).</s><s>Objective: We sought to characterize the genetic cause and clinical spectrum of Hz/Hc.</s><s>Methods: Proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1) gene sequencing was performed in 14 patients with Hz/Hc, and their clinical phenotype was compared with that of 11 patients with pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome.</s><s>PSTPIP1-pyrin interactions were analyzed by means of immunoprecipitation and Western blotting.</s><s>A structural model of the PSTPIP1 dimer</s></p></div>
			</abstract>
		</profileDesc>
	</teiHeader>
	<text xml:lang="en">
		<body>
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>was generated.</s><s>Cytokine profiles were analyzed by using the multiplex immunoassay, and MRP8/14 serum concentrations were analyzed by using an ELISA.</s><s>Results: Thirteen patients were heterozygous for a missense mutation in the PSTPIP1 gene, resulting in a p.E250K mutation, and 1 carried a mutation resulting in p.E257K.</s><s>Both mutations substantially alter the electrostatic potential of the PSTPIP1 dimer model in a region critical for protein-protein interaction.</s><s>Patients with Hz/Hc have extremely high MRP8/14 concentrations (2045 6 1300 mg/mL) compared with those with PAPA syndrome (116 6 74 mg/mL) and have a distinct clinical phenotype.</s><s>A specific cytokine profile is associated with Hz/Hc.</s><s>Hz/Hc mutations altered protein binding of PSTPIP1, increasing interaction with pyrin through phosphorylation of PSTPIP1.</s><s>Conclusion: Mutations resulting in charge reversal in the y-domain of PSTPIP1 (E/K) and increased interaction with pyrin cause a distinct autoinflammatory disorder defined by clinical and biochemical features not found in patients with PAPA syndrome, indicating a unique genotype-phenotype correlation for mutations in the PSTPIP1 gene.</s><s>This is the first inborn autoinflammatory syndrome in which inflammation is driven by uncontrolled release of members of the alarmin family.</s><s>(J Allergy Clin Immunol 2015;136:1337-45.)</s><s>]<ref type="bibr" target="#b9">[10]</ref> Highly increased serum concentrations of MRP8/14 complexes (calprotectin) have been reported in patients with systemic juvenile idiopathic arthritis (SJIA) and familial Mediterranean fever (FMF; OMIM #249100). <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref></s><s>]<ref type="bibr" target="#b14">[15]</ref> Proline-serine-threonine phosphatase-interacting protein 1 (PSTPIP1; also known as CD2BP1) is a cytoskeleton-associated adaptor protein that modulates T-cell activation, <ref type="bibr" target="#b15">16</ref> cytoskeletal organization, and IL-1b release. <ref type="bibr" target="#b16">17</ref></s><s>Heterozygous mutations in the PSTPIP1 gene cause the dominantly inherited pyogenic arthritis, pyoderma gangrenosum, and acne (PAPA) syndrome (OMIM #604410).</s><s>PAPA syndrome is a rare autosomal dominant autoinflammatory disease typically caused by the missense mutations p.A230T (c.688G&gt;A) and p.E250Q (c.748G&gt;C) in PSTPIP1. <ref type="bibr" target="#b17">18</ref></s><s>Mutations causing PAPA syndrome are thought to disrupt the interaction of PSTPIP1 with a protein tyrosin phophatese (PTP-PEST), a regulatory phosphatase, leading to uncontrolled secretion of IL-1b, probably through binding to pyrin, which is mutated in patients with FMF. <ref type="bibr" target="#b18">19</ref></s><s>Patients with PAPA syndrome typically present with recurrent sterile pyogenic arthritis in childhood, occurring spontaneously or after minor trauma.</s><s>In adolescence the propensity for cutaneous inflammation increases, encompassing severe cystic acne, and recurrent pyoderma gangrenosum-like ulcers, including the positive pathergy phenomenon. <ref type="bibr" target="#b19">20</ref></s><s>n contrast, systemic inflammation, failure to thrive, and high mortality are not part of the clinical picture of PAPA syndrome.</s></p><p><s>In this study, for the first time, we identified de novo p.E250K and p.E257K mutations in the PSTPIP1 gene as the cause of Hz/Hc disease and characterized this autoinflammatory entity in comparison with PAPA syndrome.</s><s>We here describe the first inherited syndrome in which the inflammatory pathogenesis is largely driven by unrestrained release of proinflammatory danger signals of the alarmin family.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>METHODS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Patients and samples</head><p><s>immunoperoxidase method, as previously described. <ref type="bibr" target="#b2">3</ref></s><s>Zinc serum levels were determined by using atomic absorption spectroscopy.</s><s>Normal serum levels were defined as 11.5 to 21.4 mmol/L (95% CI).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Analysis of anti-neutrophil antibodies</head><p><s>Neutrophil-reactive antibodies were detected by using the agglutination, microscopic immunofluorescence, and mAb-specific immobilization of neutrophil antigen assay, as previously described. <ref type="bibr" target="#b22">23</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genotype analysis</head><p><s>In patients with Hz/Hc, exons 1 to 15 of the PSTPIP1 gene and all 10 exons of the Mediterranean fever gene were sequenced.</s><s>PCR amplification products of exons were purified with the ExoSAP-IT reagent (USB, Cleveland, Ohio) and sequenced with the ABI PRISM Big Dye Terminator v3.1 Ready Reaction Cycle Sequencing kit and the ABI PRISM 3130 Genetic Analyzer (Applied Biosystems, Foster City, Calif).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Structural model and sequence alignment</head><p><s>The PSTPIP1 sequence (residues 3-285, UniProtKB code O43586) was defined as the target, and the F-bar domain of FCHo2 (PDB ID 2V0O, residues 2-271) with a sequence identity of 23% served as the template. <ref type="bibr" target="#b23">24</ref></s><s>Homology models were based on an alignment using the Clustal Omega tool <ref type="bibr" target="#b24">25</ref> and built with the MODELLER program. <ref type="bibr" target="#b25">26</ref></s><s>One thousand models were calculated and clustered, and the model with the best ANOLEA score <ref type="bibr" target="#b26">27</ref> belonging to the largest cluster was further refined.</s><s>A dimeric structure was generated by aligning 2 copies of the resulting model with chains A and B of the x-ray structure 2V0O and minimizing them by using the CHARMM22 all-atom force field. <ref type="bibr" target="#b27">28</ref></s><s>tructural models for the mutant proteins p.E250K and p.E257K, as well as for the PAPA syndrome mutant p.E250Q, were generated by mutating the respective amino acids of the dimer model and reminimizing the structure.</s><s>For each of the 4 models, the electrostatic potential was calculated with the UHBD code. <ref type="bibr" target="#b28">29</ref></s><s>The FoldX program was used to perform an in silico alanine scan by mutating each residue to an alanine and estimating the resulting change in folding energy. <ref type="bibr" target="#b29">30</ref></s><s>Molecular visualization was done with CHIMERA. <ref type="bibr" target="#b30">31</ref></s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Immunoprecipitation and phosphorylation of PSTPIP1</head><p><s>HEK293 cells were transfected (PolyFect; Qiagen, Hilden, Germany) with wild-type (WT) enhanced green fluorescent protein-PSTPIP1 or p.E250Q or p.E250K mutated enhanced green fluorescent protein-PSTPIP1 and pyrin for coprecipitation or cAbl (31284;pSG5-ABL; Addgene, Cambridge, Mass) for detection of tyrosine phosphorylated proteins.</s><s>Transfected HEK cells were incubated in lysis buffer (50 mmol/L Tris [pH 7.7], 300 mmol/L NaCl, 2 mmol/L MgCl, 0.1% Chaps, and protease inhibitor cocktail; Roche, Mannheim, Germany) for 20 minutes on ice and pushed through a 15-gauge cannula.</s><s>For detection of phosphotyrosine, 0.4 mmol/L Na 3 VO 4 was added to lysis buffer.</s><s>After centrifugation, supernatants were incubated overnight at 48C for coprecipitation of pyrin or for 3 hours at 48C for detection of tyrosine phosphorylated proteins with antibody (mouse a-PSTPIP1 [ab88474]; Abcam, Cambridge, United Kingdom) linked to a/g agarose beads (Pierce Biotechnology, Rockford, Ill).</s><s>After washing, samples were analyzed by means of SDS-PAGE and Western blotting with appropriate antibodies (rabbit a-PSTPIP1 [HPA 010600]; Atlas Antibodies, Stockholm, Sweden; mouse a-phosphotyrosine [4G10]; Merck Millipore, Darmstadt, Germany).</s><s>Additionally, coimmunoprecipitation band intensities of blots from 3 independent experiments were densitometrically analyzed with ImageJ 1.46r (National Institutes of Health, Bethesda, Md).</s><s>All values were normalized to the PSTPIP1 value.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Extracellular cytokine measurement</head><p><s>Cytokines and soluble receptors were measured in serum by using a multiplex immunoassay, as previously described. <ref type="bibr" target="#b31">32</ref></s><s>Acquisition of data was performed with the FlexMap3D system (Bio-Rad Laboratories, Hercules, Calif) and xPonent v4.2 software (Luminex, Austin, Tex).</s><s>Data analyses were performed by using Bio-Plex Manager software version 6.1.1 with 5 parametric curve fitting (Bio-Rad Laboratories).</s><s>Cytokines analyzed included IL-1a, IL-1b, IL-2, IL-4, IL-15, IL-6, IL-8, IL-10, IL-12, IL-13, IL-15, IL-17, IL-18, IL-21, IL-22, IL-33, CCL2, CCL3, CCL11, CCL17, CCL18, CCL22, CXCL9, granulocyte colony-stimulating factor, GM-CSF, macrophage colony-stimulating factor, IFN-a, IFN-g, macrophage migration inhibitory factor (MIF), intercellular adhesion molecule, vascular cell adhesion molecule, receptor activator of nuclear factor kB ligand, IFN-g-induced protein 10, and TNF-a.</s><s>Serum samples for this analysis were immediately frozen and shipped on dry ice.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Statistical analysis</head><p><s>Statistical analyses were performed with Prism 5.0 software (GraphPad Software, La Jolla, Calif).</s><s>Analyses between 2 groups were performed with an unpaired 2-tailed Student t test.</s><s>Comparisons among 3 or more groups were performed by using 1-way ANOVA, followed by Bonferroni multiple means tests for comparing all pairs of columns.</s><s>Differences in protein serum profiles were analyzed by using the Mann-Whitney U test.</s><s>Differences were considered statistically significant at a P value of less than .05.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>RESULTS</head></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Characterization of clinical phenotype in patients with Hz/Hc</head><p><s>Patients with Hz/Hc had a persistent early-onset (median age at disease onset, 13 months) inflammatory disease characterized by cutaneous inflammation (12/14), (hepato)splenomegaly (12/14), failure to thrive (9/14), lymphadenopathy (6/14), and joint involvement (arthritis in 7/14 and arthralgia/morning stiffness in 2/14).</s><s>Most of these patients showed marked abnormalities in hematologic parameters, including neutropenia (14/14), anemia (hemoglobin, &lt;100 g/L; n 5 13/14), and thrombocytopenia (7/14, see Table <ref type="table">E1</ref>).</s><s>As a consequence of the detected pancytopenia, bone marrow biopsy specimens were analyzed in 8 patients showing dyserythropoiesis, fibrosis, and lymphocytosis.</s><s>Additionally, the frequency of anti-neutrophil antibodies was screened in serum of 12 of 14 patients with Hz/Hc and 9 of 11 patients with PAPA syndrome.</s><s>We found a constellation of autoimmune neutropenia (AIN) in 4 patients and a constellation consistent with AIN (without identification of antigen) in 4 other patients with Hz/Hc (66% together), whereas only in 3 patients with classical PAPA syndrome could such a constellation be found (33%, see Table <ref type="table">E3</ref>  Interestingly, in the cohort of patients with PAPA syndrome (n 5 11) the most relevant clinical findings of anemia, neutropenia, thrombocytopenia, (hepato)splenomegaly, and failure to thrive were absent (see Table <ref type="table">E2</ref>).</s><s>Inversely, pyogenic arthritis, a prominent clinical feature of PAPA syndrome (n 5 8/11) was present in only 1 patient with Hz/Hc.</s><s>The only common clinical symptom in both groups was skin inflammation (PAPA syndrome, n 5 9/11; Hz/Hc, n 5 12/14), which appeared in a variety of manifestations.</s><s>The significance of the differences in the clinical phenotype and laboratory findings is depicted in Cutaneous inflammation was characterized by an unspecific infiltrate composed of neutrophils and macrophages admixed with plasma cells, as well as perivascular lymphocellular infiltrations in 5 patients with Hz/Hc.</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Genetic studies</head><p><s>Interestingly, genetic analyses of patients with Hz/Hc revealed in all of them an amino acid exchanges from the acidic glutamic acid to basic lysine.</s><s>In patients P1 to P13, the heterozygous G&gt;A transition at the c.748 position in exon 11 of the PSTPIP1 gene, leading to the missense p.E250K variant, was found. <ref type="bibr" target="#b20">21</ref></s><s>In patient P14 the heterozygous G&gt;A transition at c.769 position, also in exon 11 and leading to the missense p.E257K variant, was found.</s><s>Multiple sets of evidence indicate that these 2 variants are very likely deleterious for the structure, function, or both of PSTPIP1: their absence in the database of genomic diversity (0% allele frequency for the 2 variants in the 1000 Genomes project), in silico analyses with the algorithms SIFT and Polyphen-2 (deleterious and probably damaging), and family-based cosegregation studies.</s><s>Parental DNA was available from patients P2 to P8, P12, and P13, which confirmed a de novo mutation in 8 patients.</s><s>Patients P9 (father) and P8 (son) shared the same PSTPIP1 E250K mutation, and both were affected with a variable clinical expression.</s></p><p><s>In all patients carrying the mutations, we detected excessively increased MRP8/14 and zinc serum levels compatible with earlier findings reported in patients with Hz/Hc (see Table <ref type="table">E1</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Alteration of electrostatic potential of PSTPIP1</head><p><s>Both 250 and 257 residues are located on the convex face of the dimeric PSTPIP1 model, close to the dimer interface but exposed to the solvent (Fig <ref type="figure" target="#fig_3">2, A</ref>).</s><s>Because a helices have a periodicity of 3.6, both mutations point to the same face of the helix and to the outside of the structure.</s><s>Moreover, copies of E250 and, to a lesser degree, E257 from chains A and B are in proximity, suggesting that their influence could be potentiated in the dimer.</s><s>E250 is located in a cluster of 4 negatively charged side chains formed by D246, E247, E250, and E251 (Fig 2 <ref type="figure">, B</ref>).</s><s>An in silico alanine scan suggests that neither E250 nor E257 is relevant for the structural integrity of the protein.</s><s>The electrostatic potential projected on the molecular surface of the PSTPIP1 model (</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Binding of pyrin and phosphorylation of PSTPIP1</head><p><s>The PAPA syndrome-associated p.E250Q mutation causes increased pyrin binding and hyperphosphorylation of PSTPIP1.</s><s>Therefore we tested the effect of the p.E250K mutation on phosphorylation and pyrin binding.</s><s>Relative to the E250Q mutant, the E250K mutant exhibits markedly increased binding to pyrin (Fig <ref type="figure" target="#fig_4">3, A</ref>).</s><s>The 2 mutant proteins were hyperphosphorylated relative to WT in the presence of the cAbl kinase (Fig <ref type="figure" target="#fig_4">3, B</ref>).</s><s>Although the increase in PSTPIP1-pyrin binding was significant, phosphorylation only showed a tendency toward stronger p.E250K hyperphosphorylation (Fig 3 <ref type="figure">, C</ref>).</s></p><p><s>Serum concentration of MRP8/14 and zinc in patients with PSTPIP1 mutations Serum samples were obtained at the time of clinical and serologic active disease.</s><s>Serum concentrations of MRP8/14 in patients with Hz/Hc (mean 6 95% CI, 2070 6 1190 mg/mL) were found to be significantly increased (up to 20-fold) compared with those in patients with PAPA syndrome (116 6 74 mg/mL, P &lt; .001;</s><s>Fig <ref type="figure" target="#fig_5">4, A</ref>).</s><s>Levels in healthy control subjects were 0.48 6 0.1 mg/mL. <ref type="bibr" target="#b32">33</ref></s><s>We have previously shown that MRP8/14 levels are increased in patients with SJIA and FMF at the time of clinical and serologic active disease. <ref type="bibr" target="#b10">11,</ref><ref type="bibr" target="#b11">12</ref></s><s>However, the MRP8/14 levels in patients with Hz/Hc were more than 20 or 40 times higher than those in patients with FMF (110 6 82 mg/mL) or SJIA (45 6 13 mg/mL, both P &lt; .001),</s><s>respectively.</s><s>There were no significant differences among patients with PAPA syndrome, FMF, and SJIA.</s><s>Concomitantly, zinc levels were found to be significantly increased in patients with Hz/Hc (114.5 6 28.3 mmol/L) compared with those in patients with PAPA syndrome (21.9 6 7.8 mmol/L), FMF (14 6 8 mmol/L), and SJIA (12.1 6 1.9 mmol/L) or healthy control subjects (12.8 6 1.0 mmol/L, all P &lt; .001;</s><s>Fig 4 <ref type="figure">, B</ref>).</s><s>The degree of increase in MRP8/14 and zinc levels correlated closely in the entire patient cohort (r 5 0.838, P &lt; .001;</s><s>Fig <ref type="figure" target="#fig_5">4, C</ref>).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Serum cytokine profile of Hz/Hc and PAPA syndrome</head><p><s>In view of the increased MRP8/14 levels detected in patients with Hz/Hc, we investigated the profile of circulating cytokines to define an inflammatory signature using serum samples obtained during active disease from 8 patients with Hz/Hc (7 with p.E250K and 1 with p.E257K), 5 patients with PAPA syndrome (2 with p.A230T, 2 with p.E250Q, and 1 with p.E256G), and 22 healthy control subjects (female/male sex, 12/10; age range, 3-16 years).</s><s>All samples were obtained at the time of clinical and serologic active disease.</s><s>Expression levels were stratified into (1) cytokines that were only upregulated or downregulated in patients with Hz/Hc (ie, IL-2, IL-15, IL-22, and IFN-g); (2) cytokines that were upregulated in patients with Hz/Hc and those with PAPA syndrome but significantly higher in patients with Hz/Hc (ie, IL-8, IL-18, and IL-33); and (3) cytokines that were significantly upregulated or downregulated in patients with Hz/Hc and those with PAPA syndrome compared with control subjects (ie, IL-1b, IL-4, IL-6, IL-10, CCL2, CCL3, CCL17, CCL18, CCL22, CXCL9, intercellular adhesion molecule, vascular cell adhesion molecule, IFN-a, macrophage colony-stimulating factor, and MIF).</s><s>Levels of IL-1a, IL-5, IL-12, IL-13, IL-17, IL-21, CCL11,  <ref type="table">E4</ref> in this article's Online Repository at www.jacionline.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>Response to treatment</head><p><s>Response to treatment was evaluated in all patients with Hz/Hc (see Table <ref type="table">E5</ref> in this article's Online Repository at www. jacionline.org).</s><s>Interestingly, no consistently effective therapy was observed.</s><s>Best responses were noted when using IL-1 inhibitors, either anakinra (n 5 4) or canakinumab (n 5 1), but there were a few patients who were unresponsive to this therapy (n 5 5).</s><s>Treatment with cyclosporine (n 5 5) or prednisolone (n 5 6) resulted in a partial response.</s><s>Of note, cutaneous symptoms, arthritis, anemia, and systemic inflammation improved, but neutropenia persisted in all patients after treatment.</s><s>In 3 patients (hepato)splenomegaly resolved with treatment.</s></p><p><s>Serum profiles of cytokines, MRP8/14, and zinc were investigated in paired samples of 4 patients with a partial response to IL-1 or TNF inhibition or GM-CSF and 4 patients with no response to IL-1 or TNF inhibition and a flare under continuous treatment with cyclosporine.</s><s>Partial response to treatment was accompanied in all 4 treated patients by a decrease of IL-8, IL-18, IL-33, IL-6, CCL18, MIF, MRP8/14, and zinc serum concentrations (see Figs E1 and E2 in this article's Online Repository at www.jacionline.org).</s></p></div>
<div xmlns="http://www.tei-c.org/ns/1.0"><head>DISCUSSION</head><p><s>Hz/Hc is an autoinflammatory disorder characterized by chronic systemic inflammation, prominent skin inflammation, arthralgia/arthritis, hepatosplenomegaly, pancytopenia, and failure to thrive. <ref type="bibr" target="#b1">2</ref> A hallmark of the disease is the extreme increase in serum concentrations of the proinflammatory alarmins MRP8 and MRP14 and concomitantly zinc.</s><s>In this study we report the genetic cause for this disorder, namely a single amino acid substitution in the y-domain of PSTPIP1 (E/K) either at position p.E250 or p.E257.</s><s>Clinically, Hz/Hc is distinct from the other PSTPIP1-associated disease, PAPA syndrome, based on the presence of a severe course and early-onset disease, hepatosplenomegaly, and failure to thrive.</s><s>Variable expressivity of disease was noted both in patients with Hz/Hc and those with  PAPA syndrome, with patient P8 showing a weaker phenotype than his father (patient P9) in the cohort with Hz/Hc.</s><s>Incomplete penetrance has been previously reported in families with PAPA syndrome <ref type="bibr" target="#b20">21</ref> and seems also to be a feature of the p.E250K mutation.</s><s>Two patients with Hz/Hc died of postoperative complications after liver transplantation or sepsis.</s></p><p><s>Regarding laboratory findings, Hz/Hc is characterized by severe anemia and neutropenia, which is present in all patients and accompanied by thrombocytopenia in most patients.</s><s>By contrast, anemia and neutropenia were not or only rarely observed in patients with PAPA syndrome.</s><s>Bone marrow aspirates in patients with Hz/Hc showed evidence of dysgranulopoiesis and dyserythropoiesis, which is consistent with observed pancytopenia.</s><s>It is yet unclear whether the hematologic findings are related to chronic inflammation or could be the result of altered PSTPIP1 function.</s><s>PSTPIP1 is known to regulate neutrophil and macrophage functions, <ref type="bibr" target="#b33">34,</ref><ref type="bibr" target="#b34">35</ref> but its role in cell maturation has not been reported.</s><s>Because of the severe neutropenia, we were not able to perform functional studies with purified neutrophils.</s><s>In addition, patients with Hz/Hc could be clearly separated from patients with PAPA syndrome based on extremely high MRP8/14 and zinc serum levels.</s><s>In summary, these data suggest a unique genotype-phenotype correlation for mutations in the PSTPIP1 gene.</s><s>MRP8/14 alarmins have been identified as endogenous ligands for TLR4-mediated expression of proinflammatory cytokines, chemokines, NADPH oxidase, or adherence molecules. <ref type="bibr" target="#b0">1,</ref><ref type="bibr" target="#b5">6,</ref><ref type="bibr" target="#b6">7,</ref><ref type="bibr" target="#b10">11</ref></s><s>he extremely high expression of this endogenous TLR4 ligand in patients with Hz/Hc suggests a role for MRP8/14 in the pathogenesis of severe PSTPIP1-mediated inflammation.</s><s>In addition, patients with Hz/Hc could be clearly differentiated from those with PAPA syndrome based on a distinct cytokine profile (Table <ref type="table">E3</ref>).</s><s>]<ref type="bibr" target="#b38">[39]</ref> Hyperzincemia is caused by the zinc-capturing properties of MRP8/14, 2 and zinc levels are increased in patients with Hz/Hc but not in patients with PAPA syndrome, FMF, or SJIA.</s><s>Usually inflammation induces a reduction in plasma zinc concentrations because of redistribution in the cellular compartment. <ref type="bibr" target="#b38">39</ref></s><s>In patients with sepsis, lower plasma zinc concentrations were associated with higher illness scores and increased cytokine production. <ref type="bibr" target="#b39">40</ref></s><s>Therefore the unique high zinc levels in patients with Hz/Hc are interesting observations in an inflammatory context.</s><s>2]<ref type="bibr" target="#b42">[43]</ref><ref type="bibr" target="#b43">[44]</ref> Conversely, in promonocytic cells zinc increased both IL-6 and IL-8 levels, <ref type="bibr" target="#b44">45</ref> and under inflammatory conditions, IFN-g gene expression seems to be reduced by zinc deficiency. <ref type="bibr" target="#b45">46,</ref><ref type="bibr" target="#b46">47</ref></s><s>Therefore hyperzincemia might contribute to the high IL-2, IL-6, IL-8, and IFN-g levels found in patients with Hz/Hc.</s></p><p><s>Among the identified cytokines, some are characteristic for the T-cell compartment as IL-2 or IL-22, indicating a role of the adaptive immune system in patients with Hz/Hc.</s><s>Additionally, in a murine model of systemic autoimmune disease, we have shown that MRP8 and MRP14 expression at the site of inflammation is essential for the development of autoreactive T cells and promotion of systemic autoimmunity. <ref type="bibr" target="#b7">8</ref></s><s>This mechanism might enhance inflammation in the chronic phase of this autoinflammatory syndrome.</s><s>Although B-cell distribution was normal in patients with Hz/Hc and those with PAPA, we found serologic constellations of AIN as a result of anti-neutrophil antibody production in both phenotypes (66% vs 33% of samples).</s><s>Because autoantibodies were not found in all neutropenic patients, this seems not to be the only responsible mechanism.</s><s>However, AIN might contribute to neutropenia in patients with Hz/Hc and seems to be a result of the activation of the adaptive immune system within an autoinflammatory disease.</s></p><p><s>The p.E250K and p.E257K substitutions in PSTPIP1 are located within the coiled-coil region, which is important for pyrin and PTP-PEST interaction.</s><s>The electrostatic modeling of PSTPIP1 displays a large negative patch in the critical region that is significantly affected by both mutations but not found for the classical PAPA-associated mutation E250Q.</s><s>The PAPA-causing mutations have been shown to disrupt PSTPIP1-PEST phosphatase interactions, resulting in hyperphosphorylation of PSTPIP1 and increased pyrin avidity. <ref type="bibr" target="#b18">19</ref></s><s>This binding might release pyrin from its autoinhibition, triggering increased apoptosis-associated speck-like protein containing a carboxyterminal CARD oligomerization and caspase-1 activation. <ref type="bibr" target="#b47">48</ref></s><s>urthermore, the increased PSTPIP1-pyrin avidity also results in altered PSTPIP1 cellular distribution and its greater colocalization with the apoptosis-associated speck-like protein containing a carboxy-terminal CARD inflammasome. <ref type="bibr" target="#b18">19</ref></s><s>We showed that p.E250K mutation increases PSTPIP1-pyrin interactions compared with p.E250Q.</s><s>The pE250K-mutated PSTPIP1 protein shows comparable hyperphosphorylation with p.E250Q indicating that the increased PSTPIP1-pyrin binding is not just dependent on the phosphorylation status of the protein.</s><s>These data are in accordance with earlier reports indicating a role of the coiled-coil domain of PSTPIP1 in addition to phosphorylation of tyrosine Y344 in the binding of pyrin. <ref type="bibr" target="#b16">17</ref></s><s>The fact that a single negative charge switch in PSTPIP1 causes major phenotypic changes with clinical significance is unique for this group of autoinflammatory diseases, and the analysis of the underlying molecular mechanism will be a challenging matter for future research.</s><s>Because significantly increased MRP8/14 levels can be found in patients with FMF and those with PAPA syndrome and are extremely high in patients with Hz/Hc, it seems to be likely that the MRP secretion is regulated by the pyrin-PSTPIP1 axis.</s><s>A link might be the involvement of tubulin in the pyrin-PSTPIP1 axis <ref type="bibr" target="#b18">19,</ref><ref type="bibr" target="#b48">49</ref> because MRPs are released in an alternative tubulin-dependent manner. <ref type="bibr" target="#b3">4</ref></s><s>Patients with cryopyrinassociated periodic syndromes with mutations in the NOD-like receptor family, pyrin domain, containing 3 gene have MRP8/14 levels within the range of systemic infections. <ref type="bibr" target="#b49">50</ref></s><s>herefore highly increased serum levels of MRP8/14 are the first specific biomarker for diseases affecting NOD-like receptor family, pyrin domain containing 3-independent inflammasome activation. <ref type="bibr" target="#b50">51,</ref><ref type="bibr" target="#b51">52</ref></s><s>he efficacy of anti-TNF treatment and inconsistent efficacy of recombinant IL-1RA (anakinra) treatment of patients with PAPA syndrome have been reported. <ref type="bibr" target="#b20">21</ref></s><s>Reports about treatment of Hz/Hc are limited, with preliminary evidence for favorable treatment with cyclosporine <ref type="bibr" target="#b14">15</ref> and adalimumab. <ref type="bibr" target="#b52">53</ref></s><s>In our cohort of patients with HZ/Hc, IL-1 blockade was partially effective in 5 of 10 patients; cyclosporine or prednisolone showed reasonable responses as well.</s><s>Anti-TNF treatment was only effective in 1 of 3 patients.</s><s>Interestingly, improvement in cutaneous symptoms, arthritis, anemia, systemic inflammation, and hepatosplenomegaly was noted, whereas neutropenia was still present in all 3 patients.</s><s>Therefore our data indicate the necessity for an individual tailored treatment regimen.</s><s>Response to treatment was accompanied by a decrease in levels of serum proteins, including IL-18 and MRP8/14.</s></p><p><s>This study reports the largest cohort of patients with PSTPIP1 mutations.</s><s>PSTPIP1-associated diseases show variable expressivity and are associated with a range of clinical phenotypes.</s><s>To avoid confusion, we would like to suggest a novel nomenclature for this group of related diseases that is based on the causal genotypes, biochemical findings, and clinically distinct symptoms.</s><s>In analogy to cryopyrin-associated periodic syndrome, we suggest the term PSTPIP1-associated inflammatory diseases (PAID) as a new class that encompasses PAPA syndrome (p.A230T, p.E250Q, and p.E256G), pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa syndrome (p.E277D) <ref type="bibr" target="#b53">54</ref> and patients with Hz/Hc (p.E250K and p.E257K).</s><s>We would like to suggest the term PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome (PAMI) for the latter entity.</s><s>We further propose that patients with undefined autoinflammatory syndromes and significant skin inflammation (or pyoderma gangrenosum) should be tested for MRP8/14 serum levels to initiate targeted genetic testing.</s></p><p><s>In conclusion, an amino acid change in the y-domain of PSTPIP1 (E/K) causes a clinically and serologically distinct autoinflammatory disorder representing a novel and unique genotype-phenotype correlation.</s><s>The PSTPIP1-associated myeloid-related proteinemia inflammatory syndrome (Hz/Hc) inflammatory phenotype is associated with a characteristic cytokine profile and characterized by extremely high levels of the proinflammatory alarmins MRP8 and MRP14.</s></p></div><figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_0"><head>Fig 1 ,</head><label>1</label><figDesc><div><p><s>A (median age at disease onset in patients with PAPA syndrome, 4 years).</s><s>Among cutaneous findings, palpebral lesions occurred in 2 patients with Hz/Hc (Fig 1, B), whereas they were absent in patients with PAPA syndrome.</s><s>Patient P1 had pyoderma gangrenosum (Fig 2, C) and several ulcers in the lower extremities (Fig 1, D and E).</s><s>Here, biopsy samples from affected and unaffected skin showed a dramatic upregulation of MRP8 and MRP14 in hyperproliferative epidermis and marked leukocyte infiltration in inflamed dermis (Fig 1, F and G) in contrast to clinically unaffected skin from the same patient (Fig 1, H and I).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_1"><head>Fig 2 ,</head><label>2</label><figDesc><div><p><s>C and D) displays a large negative patch in the central part of the convex face that has been proposed to be important for pyrin and PTP-PEST binding.</s><s>Both mutants, p.E250K and p.E257K, substantially affect this negative patch of WT PSTPIP1 (Fig 2, E and F), whereas the influence of the PAPA syndrome mutant p.E250Q on the electrostatic potential is much less pronounced (Fig 2, G).</s></p></div></figDesc></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_2"><head>FIG 1 .</head><label>1</label><figDesc><div><p><s>FIG 1. Hz/Hc can be distinguished from PAPA syndrome based on clinical symptoms and laboratory parameters.</s><s>A, Characteristic clinical symptoms and laboratory parameters present or absent in patients with Hz/Hc and those with PAPA syndrome.</s><s>B-I, Palpebral lesions (Fig 1, B), pyoderma gangrenosum-like ulcers (Fig 1, C) or ulcerative dermatitis (Fig 1, D and E), and MRP14 expression in affected (Fig 1, F and G) and unaffected (Fig 1, H and I) skin of patient 1.</s></p></div></figDesc><graphic coords="4,70.70,65.59,179.71,495.61" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_3"><head>FIG 2 .</head><label>2</label><figDesc><div><p><s>FIG 2. Mutations of patients with Hz/Hc alter the electrostatic potential of PSTPIP1.</s><s>A, PSTPIP1 FCH domain in a ribbon diagram of PSTPIP1 dimer with Hz/Hc mutations (green).</s><s>B, p.E250 in a cluster of 4 negatively charged side chains.</s><s>C-G, Electrostatic potential in (blue, positive charge; red, negative charge; Fig 2, C) in WT (Fig 2, D), p.E250K (Fig 2, E), p.E257K (Fig 2, F), and p.E250Q mutants (Fig 2, G).=</s></p></div></figDesc><graphic coords="5,46.72,65.59,235.39,629.69" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_4"><head>FIG 3 .</head><label>3</label><figDesc><div><p><s>FIG 3. p.E250K mutation increases PSTPIP1-pyrin binding.</s><s>A, Cotransfection with pyrin and PSTPIP1 WT or p.E250Q or p.E250K mutants.</s><s>Immunoprecipitation (IP) was performed with anti-PSTPIP1 and immunoblotted with anti-pyrin and anti-PSTPIP1.</s><s>B, Cotransfection with PSTPIP1 WT, p.E250Q or p.E250K mutants, and cAbl.</s><s>Immunoprecipitation with anti-PSTPIP1, phosphorylation was detected with anti-phosphotyrosine. C, Relative band intensity was measured and expressed as n-fold to PSTPIP1 WT. *P &lt; .05.</s></p></div></figDesc><graphic coords="6,71.26,65.59,178.53,296.62" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_5"><head>FIG 4 .</head><label>4</label><figDesc><div><p><s>FIG 4. Patients with Hz/Hc can be distinguished from those with PAPA syndrome, FMF, or SJIA based on MRP8/14 and zinc serum levels.</s><s>A and B, MRP8/14 (Fig 4, A) and zinc (Fig 4, B) serum levels in patients with active disease (patients with Hz/Hc, n 5 13; patients with PAPA syndrome, n 5 11), patients with FMF (n 5 20), patients with SJIA (n 5 20), or healthy control subjects (n 5 20).</s><s>C, Correlation of MRP8/14 and zinc levels in all patients.</s><s>*P &lt; .05 and ***P &lt; .001.</s></p></div></figDesc><graphic coords="6,348.89,65.59,143.47,373.78" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" xml:id="fig_6"><head>FIG 5 .</head><label>5</label><figDesc><div><p><s>FIG 5. Patients with Hz/Hc can be distinguished from patients with PAPA syndrome and healthy control subjects based on serum protein expression levels.</s><s>Protein serum concentration levels were classified by differential expression between patients with Hc/Hz, patients with PAPA syndrome, and control subjects.</s><s>Expression values are normalized for each gene to the healthy group.</s><s>Transformed expression levels are indicated by color scale with relatively high (red) and relatively low (blue) expression.</s></p></div></figDesc><graphic coords="7,44.84,65.59,239.02,309.60" type="bitmap" /></figure>
<figure xmlns="http://www.tei-c.org/ns/1.0" type="table" xml:id="tab_0"><head></head><label></label><figDesc><div><p><s>in this article's Online Repository at www.jacionline.org).</s><s>Analysis of B-cell subpopulations (total [CD19 1 ], transitional [CD24 11 and CD38 11 ], naive [CD27 2 , IgG 2 , and IgA 2 ], memory [CD27 1 ], IgM memory [CD27 1 , IgG 2 , and IgA 2 ], and switched memory [CD27 1 , IgG 1 , and IgA 1 ]) did not show relevant changes in 5 patients</s></p></div></figDesc><table><row><cell>with Hz/Hc (E250K) or 5 patients with PAPA syndrome</cell></row><row><cell>(3 E250Q and 2 E256G) when compared directly or with healthy</cell></row><row><cell>control subjects.</cell></row></table></figure>
			<note xmlns="http://www.tei-c.org/ns/1.0" place="foot">J ALLERGY CLIN IMMUNOL VOLUME 136, NUMBER 5</note>
		</body>
		<back>

			<div type="acknowledgement">
<div xmlns="http://www.tei-c.org/ns/1.0"><p><s>We thank Melanie Saers and Susanne Schleifenbaum for excellent technical assistance, Professor Jerzy-Roch Nofer for laboratory analysis, and Professor Anna Simon for providing clinical data.</s></p></div>
			</div>

			<div type="references">

				<listBibl>

<biblStruct xml:id="b0">
	<analytic>
		<title level="a" type="main">Mrp8 and Mrp14 are endogenous activators of Toll-like receptor 4, promoting lethal, endotoxin-induced shock</title>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Tenbrock</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Leukert</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Ehrhardt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Van Zoelen</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">13</biblScope>
			<biblScope unit="page" from="1042" to="1049" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b1">
	<analytic>
		<title level="a" type="main">Hyperzincaemia and hypercalprotectinaemia: a new disorder of zinc metabolism</title>
		<author>
			<persName><forename type="first">B</forename><surname>Sampson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Fagerhol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sunderkotter</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">E</forename><surname>Golden</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Richmond</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Klein</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Lancet</title>
		<imprint>
			<biblScope unit="volume">360</biblScope>
			<biblScope unit="page" from="1742" to="1745" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b2">
	<analytic>
		<title level="a" type="main">Myeloid-related proteins 8 and 14 are specifically secreted during interaction of phagocytes and activated endothelium and are useful markers for monitoring disease activity in pauciarticular-onset juvenile rheumatoid arthritis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Frosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Strey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Wulffraat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sunderkotter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">43</biblScope>
			<biblScope unit="page" from="628" to="637" />
			<date type="published" when="2000">2000</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b3">
	<analytic>
		<title level="a" type="main">Myeloid-related protein (MRP) 8 and MRP14, calcium-binding proteins of the S100 family, are secreted by activated monocytes via a novel, tubulindependent pathway</title>
		<author>
			<persName><forename type="first">A</forename><surname>Rammes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goebeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Klempt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hartmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sorg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="9496" to="9502" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b4">
	<analytic>
		<title level="a" type="main">Phagocyte-specific S100 proteins: a novel group of proinflammatory molecules</title>
		<author>
			<persName><forename type="first">J</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sorg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Sunderkotter</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Trends Immunol</title>
		<imprint>
			<biblScope unit="volume">24</biblScope>
			<biblScope unit="page" from="155" to="158" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b5">
	<analytic>
		<title level="a" type="main">Myeloid-related proteins 8 and 14 induce a specific inflammatory response in human microvascular endothelial cells</title>
		<author>
			<persName><forename type="first">D</forename><surname>Viemann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Strey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Janning</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Jurk</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Klimmek</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">105</biblScope>
			<biblScope unit="page" from="2955" to="2962" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b6">
	<analytic>
		<title level="a" type="main">The human S100 protein MRP-14 is a novel activator of the beta 2 integrin Mac-1 on neutrophils</title>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Newton</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Hogg</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">160</biblScope>
			<biblScope unit="page" from="1427" to="1435" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b7">
	<analytic>
		<title level="a" type="main">The Toll-like receptor 4 ligands Mrp8 and Mrp14 are crucial in the development of autoreactive CD81 T cells</title>
		<author>
			<persName><forename type="first">K</forename><surname>Loser</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Voskort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Lueken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kupas</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Nacken</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Med</title>
		<imprint>
			<biblScope unit="volume">16</biblScope>
			<biblScope unit="page" from="713" to="717" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b8">
	<analytic>
		<title level="a" type="main">Myeloidrelated proteins S100A8/S100A9 regulate joint inflammation and cartilage destruction during antigen-induced arthritis</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">L</forename><surname>Van Lent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Grevers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">B</forename><surname>Blom</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Sloetjes</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Mort</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">67</biblScope>
			<biblScope unit="page" from="1750" to="1758" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b9">
	<analytic>
		<title level="a" type="main">MRP8 and MRP14 control microtubule reorganization during transendothelial migration of phagocytes</title>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ludwig</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Goebeler</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Strey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><forename type="middle">S</forename><surname>Thorey</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Reichelt</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Blood</title>
		<imprint>
			<biblScope unit="volume">104</biblScope>
			<biblScope unit="page" from="4260" to="4268" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b10">
	<analytic>
		<title level="a" type="main">The myeloid-related proteins 8 and 14 complex, a novel ligand of toll-like receptor 4, and interleukin-1beta form a positive feedback mechanism in systemic-onset juvenile idiopathic arthritis</title>
		<author>
			<persName><forename type="first">M</forename><surname>Frosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Ahlmann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Vogl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Wittkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Wulffraat</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Foell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">60</biblScope>
			<biblScope unit="page" from="883" to="891" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b11">
	<analytic>
		<title level="a" type="main">The endogenous TLR-4 ligands MRP8/14 as biomarkers of inflammation in Familial Mediterranean Fever (FMF)</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wittkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Kallinich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Keitzer</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Foell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Pediatr Rheumatol Online J</title>
		<imprint>
			<biblScope unit="volume">6</biblScope>
			<biblScope unit="issue">Suppl1</biblScope>
			<biblScope unit="page">P208</biblScope>
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b12">
	<analytic>
		<title level="a" type="main">Severe anemia and neutropenia associated with hyperzincemia and hypercalprotectinemia</title>
		<author>
			<persName><forename type="first">S</forename><surname>Fessatou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">K</forename><surname>Fagerhol</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roth</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Stamoulakatou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Kitra</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Hadarean</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Pediatr Hematol Oncol</title>
		<imprint>
			<biblScope unit="volume">27</biblScope>
			<biblScope unit="page" from="477" to="480" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b13">
	<analytic>
		<title level="a" type="main">Hyperzincemia and hypercalprotectinemia: unsuccessful treatment with tacrolimus</title>
		<author>
			<persName><forename type="first">B</forename><surname>Isidor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Poignant</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Corradini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Fouassier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Quartier</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Roth</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Paediatr</title>
		<imprint>
			<biblScope unit="volume">98</biblScope>
			<biblScope unit="page" from="410" to="412" />
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b14">
	<analytic>
		<title level="a" type="main">Effects of cyclosporine A in hyperzincaemia and hypercalprotectinaemia</title>
		<author>
			<persName><forename type="first">T</forename><surname>Sugiura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Goto</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ito</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Ban</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Okada</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Moriyama</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Acta Paediatr</title>
		<imprint>
			<biblScope unit="volume">95</biblScope>
			<biblScope unit="page" from="857" to="860" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b15">
	<analytic>
		<title level="a" type="main">CD2BP1 modulates CD2-dependent T cell activation via linkage to protein tyrosine phosphatase (PTP)-PEST</title>
		<author>
			<persName><forename type="first">H</forename><surname>Yang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">L</forename><surname>Reinherz</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol</title>
		<imprint>
			<biblScope unit="volume">176</biblScope>
			<biblScope unit="page" from="5898" to="5907" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b16">
	<analytic>
		<title level="a" type="main">Pyrin binds the PSTPIP1/CD2BP1 protein, defining familial Mediterranean fever and PAPA syndrome as disorders in the same pathway</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">G</forename><surname>Shoham</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Centola</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Mansfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Hull</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wood</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">A</forename><surname>Wise</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">100</biblScope>
			<biblScope unit="page" from="13501" to="13506" />
			<date type="published" when="2003">2003</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b17">
	<analytic>
		<title level="a" type="main">Clinical, molecular, and genetic characteristics of PAPA syndrome: a review</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">J</forename><surname>Smith</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><surname>Allantaz</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Bennett</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Zhang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">X</forename><surname>Gao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Wood</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Curr Genomics</title>
		<imprint>
			<biblScope unit="volume">11</biblScope>
			<biblScope unit="page" from="519" to="527" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b18">
	<analytic>
		<title level="a" type="main">Pyrin Modulates the Intracellular Distribution of PSTPIP1</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">L</forename><surname>Waite</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Schaner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">N</forename><surname>Richards</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Balci-Peynircioglu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">L</forename><surname>Masters</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Brydges</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">4</biblScope>
			<biblScope unit="page">e6147</biblScope>
			<date type="published" when="2009">2009</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b19">
	<analytic>
		<title level="a" type="main">A new autosomal dominant disorder of pyogenic sterile arthritis, pyoderma gangrenosum, and acne: PAPA syndrome</title>
		<author>
			<persName><forename type="first">N</forename><forename type="middle">M</forename><surname>Lindor</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">M</forename><surname>Arsenault</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><surname>Solomon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>Seidman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">T</forename><surname>Mcevoy</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mayo Clin Proc</title>
		<imprint>
			<biblScope unit="volume">72</biblScope>
			<biblScope unit="page" from="611" to="615" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b20">
	<analytic>
		<title level="a" type="main">Genotype, phenotype, and clinical course in five patients with PAPA syndrome (pyogenic arthritis, pyoderma gangrenosum, and acne)</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">P</forename><surname>Demidowich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">F</forename><surname>Freeman</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">B</forename><surname>Kuhns</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Aksentijevich</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">I</forename><surname>Gallin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">L</forename><surname>Turner</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">64</biblScope>
			<biblScope unit="page" from="2022" to="2027" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b21">
	<analytic>
		<title level="a" type="main">Variable expression and treatment of PAPA syndrome</title>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Schellevis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Stoffels</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">P</forename><surname>Hoppenreijs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Bodar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Simon</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Van Der Meer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="1168" to="1170" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b22">
	<analytic>
		<title level="a" type="main">HNA-1d: a new human neutrophil antigen located on Fcgamma receptor IIIb associated with neonatal immune neutropenia</title>
		<author>
			<persName><forename type="first">A</forename><surname>Reil</surname></persName>
		</author>
		<author>
			<persName><forename type="first">U</forename><forename type="middle">J</forename><surname>Sachs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Siahanidou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">K</forename><surname>Flesch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Bux</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transfusion</title>
		<imprint>
			<biblScope unit="volume">53</biblScope>
			<biblScope unit="page" from="2145" to="2151" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b23">
	<analytic>
		<title level="a" type="main">Structure and analysis of FCHo2 F-BAR domain: a dimerizing and membrane recruitment module that effects membrane curvature</title>
		<author>
			<persName><forename type="first">W</forename><forename type="middle">M</forename><surname>Henne</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">M</forename><surname>Kent</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">G</forename><surname>Ford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">G</forename><surname>Hegde</surname></persName>
		</author>
		<author>
			<persName><forename type="first">O</forename><surname>Daumke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Butler</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Structure</title>
		<imprint>
			<biblScope unit="volume">15</biblScope>
			<biblScope unit="page" from="839" to="852" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b24">
	<analytic>
		<title level="a" type="main">Fast, scalable generation of high-quality protein multiple sequence alignments using Clustal Omega</title>
		<author>
			<persName><forename type="first">F</forename><surname>Sievers</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Wilm</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Dineen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">J</forename><surname>Gibson</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Karplus</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Li</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Syst Biol</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">539</biblScope>
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b25">
	<analytic>
		<title level="a" type="main">Comparative protein modelling by satisfaction of spatial restraints</title>
		<author>
			<persName><forename type="first">A</forename><surname>Sali</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">L</forename><surname>Blundell</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Biol</title>
		<imprint>
			<biblScope unit="volume">234</biblScope>
			<biblScope unit="page" from="779" to="815" />
			<date type="published" when="1993">1993</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b26">
	<analytic>
		<title level="a" type="main">Assessing protein structures with a non-local atomic interaction energy</title>
		<author>
			<persName><forename type="first">F</forename><surname>Melo</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><surname>Feytmans</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Biol</title>
		<imprint>
			<biblScope unit="volume">277</biblScope>
			<biblScope unit="page" from="1141" to="1152" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b27">
	<analytic>
		<title level="a" type="main">All-atom empirical potential for molecular modeling and dynamics studies of proteins</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">D</forename><surname>Mackerell</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Bashford</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Bellott</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">L</forename><surname>Dunbrack</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Evanseck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">J</forename><surname>Field</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Phys Chem B</title>
		<imprint>
			<biblScope unit="volume">102</biblScope>
			<biblScope unit="page" from="3586" to="3616" />
			<date type="published" when="1998">1998</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b28">
	<analytic>
		<title level="a" type="main">Electrostatics and diffusion of molecules in solution: simulations with the University of Houston Brownian Dynamics program</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">D</forename><surname>Madura</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">M</forename><surname>Briggs</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">C</forename><surname>Wade</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">E</forename><surname>Davis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">A</forename><surname>Luty</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Ilin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Comput Phys Commun</title>
		<imprint>
			<biblScope unit="volume">91</biblScope>
			<biblScope unit="page" from="57" to="95" />
			<date type="published" when="1995">1995</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b29">
	<analytic>
		<title level="a" type="main">Predicting changes in the stability of proteins and protein complexes: a study of more than 1000 mutations</title>
		<author>
			<persName><forename type="first">R</forename><surname>Guerois</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">E</forename><surname>Nielsen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Serrano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Mol Biol</title>
		<imprint>
			<biblScope unit="volume">320</biblScope>
			<biblScope unit="page" from="369" to="387" />
			<date type="published" when="2002">2002</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b30">
	<analytic>
		<title level="a" type="main">UCSF Chimera-a visualization system for exploratory research and analysis</title>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">F</forename><surname>Pettersen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">D</forename><surname>Goddard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">C</forename><surname>Huang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Couch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">M</forename><surname>Greenblatt</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">C</forename><surname>Meng</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Comput Chem</title>
		<imprint>
			<biblScope unit="volume">25</biblScope>
			<biblScope unit="page" from="1605" to="1612" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b31">
	<analytic>
		<title level="a" type="main">Improved multiplex immunoassay performance in human plasma and synovial fluid following removal of interfering heterophilic antibodies</title>
		<author>
			<persName><forename type="first">W</forename><surname>De Jager</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">J</forename><surname>Prakken</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Bijlsma</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Kuis</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">T</forename><surname>Rijkers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Immunol Methods</title>
		<imprint>
			<biblScope unit="volume">300</biblScope>
			<biblScope unit="page" from="124" to="135" />
			<date type="published" when="2005">2005</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b32">
	<analytic>
		<title level="a" type="main">The Toll-like receptor 4 agonist MRP8/14 protein complex is a sensitive indicator for disease activity and predicts relapses in systemic-onset juvenile idiopathic arthritis</title>
		<author>
			<persName><forename type="first">D</forename><surname>Holzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Frosch</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Kastrup</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Prince</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">H</forename><surname>Otten</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Van</forename><surname>Suijlekom-Smit</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">W</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">71</biblScope>
			<biblScope unit="page" from="974" to="980" />
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b33">
	<analytic>
		<title level="a" type="main">The PCH family member proline-serine-threonine phosphatase-interacting protein 1 targets to the leukocyte uropod and regulates directed cell migration</title>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Bennin</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Huttenlocher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Biol Cell</title>
		<imprint>
			<biblScope unit="volume">19</biblScope>
			<biblScope unit="page" from="3180" to="3191" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b34">
	<analytic>
		<title level="a" type="main">Impaired podosome formation and invasive migration of macrophages from patients with a PSTPIP1 mutation and PAPA syndrome</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Cortesio</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">A</forename><surname>Wernimont</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">L</forename><surname>Kastner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><forename type="middle">M</forename><surname>Cooper</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Huttenlocher</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Arthritis Rheum</title>
		<imprint>
			<biblScope unit="volume">62</biblScope>
			<biblScope unit="page" from="2556" to="2558" />
			<date type="published" when="2010">2010</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b35">
	<analytic>
		<title level="a" type="main">Interferon-gamma: an overview of signals, mechanisms and functions</title>
		<author>
			<persName><forename type="first">K</forename><surname>Schroder</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">J</forename><surname>Hertzog</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Ravasi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><forename type="middle">A</forename><surname>Hume</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Leukoc Biol</title>
		<imprint>
			<biblScope unit="volume">75</biblScope>
			<biblScope unit="page" from="163" to="189" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b36">
	<analytic>
		<title level="a" type="main">IL-17RE is the functional receptor for IL-17C and mediates mucosal immunity to infection with intestinal pathogens</title>
		<author>
			<persName><forename type="first">X</forename><surname>Song</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Zhu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Shi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">D</forename><surname>Levin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nat Immunol</title>
		<imprint>
			<biblScope unit="volume">12</biblScope>
			<biblScope unit="page" from="1151" to="1158" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b37">
	<analytic>
		<title level="a" type="main">IL-22-producing neutrophils contribute to antimicrobial defense and restitution of colonic epithelial integrity during colitis</title>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Zindl</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">F</forename><surname>Lai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">K</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">L</forename><surname>Maynard</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">N</forename><surname>Harbour</surname></persName>
		</author>
		<author>
			<persName><forename type="first">W</forename><surname>Ouyang</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Natl Acad Sci U S A</title>
		<imprint>
			<biblScope unit="volume">110</biblScope>
			<biblScope unit="page" from="12768" to="12773" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b38">
	<analytic>
		<title level="a" type="main">Effects of endotoxin on zinc metabolism in human volunteers</title>
		<author>
			<persName><forename type="first">L</forename><forename type="middle">M</forename><surname>Gaetke</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">J</forename><surname>Mcclain</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">T</forename><surname>Talwalkar</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">I</forename><surname>Shedlofsky</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Physiol</title>
		<imprint>
			<biblScope unit="volume">272</biblScope>
			<biblScope unit="page" from="E952" to="956" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b39">
	<analytic>
		<title level="a" type="main">A comparison of zinc metabolism, inflammation, and disease severity in critically ill infected and noninfected adults early after intensive care unit admission</title>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">Y</forename><surname>Besecker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">C</forename><surname>Exline</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Hollyfield</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><surname>Phillips</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">A</forename><surname>Disilvestro</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">D</forename><surname>Wewers</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Am J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">93</biblScope>
			<biblScope unit="page" from="1356" to="1364" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b40">
	<analytic>
		<title level="a" type="main">Evidence for reprogramming global gene expression during zinc deficiency in the HUT-78 cell line</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><surname>Li</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Sarkar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Nutrition</title>
		<imprint>
			<biblScope unit="volume">22</biblScope>
			<biblScope unit="page" from="1045" to="1056" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b41">
	<analytic>
		<title level="a" type="main">Correction of interleukin-2 gene expression by in vitro zinc addition to mononuclear cells from zinc-deficient human subjects: a specific test for zinc deficiency in humans</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">H</forename><surname>Sarkar</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Transl Res</title>
		<imprint>
			<biblScope unit="volume">148</biblScope>
			<biblScope unit="page" from="325" to="333" />
			<date type="published" when="2006">2006</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b42">
	<analytic>
		<title level="a" type="main">Zinc deficiency: changes in cytokine production and T-cell subpopulations in patients with head and neck cancer and in noncancer subjects</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">M</forename><surname>Grabowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Kaplan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><forename type="middle">H</forename><surname>Mathog</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Proc Assoc Am Physicians</title>
		<imprint>
			<biblScope unit="volume">109</biblScope>
			<biblScope unit="page" from="68" to="77" />
			<date type="published" when="1997">1997</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b43">
	<analytic>
		<title level="a" type="main">Reduced production of immunoregulatory cytokines in vitamin A-and zinc-deficient Indonesian infants</title>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">T</forename><surname>Wieringa</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><forename type="middle">A</forename><surname>Dijkhuizen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><forename type="middle">E</forename><surname>West</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Van Der Ven-Jongekrijg</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Van Der Meer</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Eur J Clin Nutr</title>
		<imprint>
			<biblScope unit="volume">58</biblScope>
			<biblScope unit="page" from="1498" to="1504" />
			<date type="published" when="2004">2004</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b44">
	<analytic>
		<title level="a" type="main">Zinc induces chemokine and inflammatory cytokine release from human promonocytes</title>
		<author>
			<persName><forename type="first">T</forename><forename type="middle">C</forename><surname>Tsou</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">R</forename><surname>Chao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">C</forename><surname>Yeh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">Y</forename><surname>Tsai</surname></persName>
		</author>
		<author>
			<persName><forename type="first">H</forename><forename type="middle">J</forename><surname>Lin</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Hazard Mater</title>
		<imprint>
			<biblScope unit="volume">196</biblScope>
			<biblScope unit="page" from="335" to="341" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b45">
	<analytic>
		<title level="a" type="main">Intracellular free zinc up-regulates IFN-gamma and T-bet essential for Th1 differentiation in Con-A stimulated HUT-78 cells</title>
		<author>
			<persName><forename type="first">B</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">S</forename><surname>Prasad</surname></persName>
		</author>
		<author>
			<persName><forename type="first">F</forename><forename type="middle">W</forename><surname>Beck</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">W</forename><surname>Bao</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Singh</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ali</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Biochem Biophys Res Commun</title>
		<imprint>
			<biblScope unit="volume">407</biblScope>
			<biblScope unit="page" from="703" to="707" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b46">
	<analytic>
		<title level="a" type="main">Attenuation of interferon-gamma mRNA expression in activated Jurkat T cells by exogenous zinc via downregulation of the calcium-independent PKC-AP-1 signaling pathway</title>
		<author>
			<persName><forename type="first">K</forename><surname>Hayashi</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><surname>Ishizuka</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Yokoyama</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Hatae</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Life Sci</title>
		<imprint>
			<biblScope unit="volume">83</biblScope>
			<biblScope unit="page" from="6" to="11" />
			<date type="published" when="2008">2008</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b47">
	<analytic>
		<title level="a" type="main">Pyrin activates the ASC pyroptosome in response to engagement by autoinflammatory PSTPIP1 mutants</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fernandes-Alnemri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><surname>Datta</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Wu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Juliana</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Solorzano</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Mol Cell</title>
		<imprint>
			<biblScope unit="volume">28</biblScope>
			<biblScope unit="page" from="214" to="227" />
			<date type="published" when="2007">2007</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b48">
	<analytic>
		<title level="a" type="main">Ribotoxic stress through p38 mitogen-activated protein kinase activates in vitro the human pyrin inflammasome</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">W</forename><surname>Yu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">A</forename><surname>Farias</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Hwang</surname></persName>
		</author>
		<author>
			<persName><forename type="first">T</forename><surname>Fernandes-Alnemri</surname></persName>
		</author>
		<author>
			<persName><forename type="first">E</forename><forename type="middle">S</forename><surname>Alnemri</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">J Biol Chem</title>
		<imprint>
			<biblScope unit="volume">288</biblScope>
			<biblScope unit="page" from="11378" to="11383" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b49">
	<analytic>
		<title level="a" type="main">MRP8 and MRP14, phagocyte-specific danger signals, are sensitive biomarkers of disease activity in cryopyrin-associated periodic syndromes</title>
		<author>
			<persName><forename type="first">H</forename><surname>Wittkowski</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">B</forename><surname>Kuemmerle-Deschner</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Austermann</surname></persName>
		</author>
		<author>
			<persName><forename type="first">D</forename><surname>Holzinger</surname></persName>
		</author>
		<author>
			<persName><forename type="first">R</forename><surname>Goldbach-Mansky</surname></persName>
		</author>
		<author>
			<persName><forename type="first">K</forename><surname>Gramlich</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Ann Rheum Dis</title>
		<imprint>
			<biblScope unit="volume">70</biblScope>
			<biblScope unit="page" from="2075" to="2081" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b50">
	<analytic>
		<title level="a" type="main">Gain-offunction Pyrin mutations induce NLRP3 protein-independent interleukin-1beta activation and severe autoinflammation in mice</title>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">J</forename><surname>Chae</surname></persName>
		</author>
		<author>
			<persName><forename type="first">Y</forename><forename type="middle">H</forename><surname>Cho</surname></persName>
		</author>
		<author>
			<persName><forename type="first">G</forename><forename type="middle">S</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><surname>Cheng</surname></persName>
		</author>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">P</forename><surname>Liu</surname></persName>
		</author>
		<author>
			<persName><forename type="first">L</forename><surname>Feigenbaum</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Immunity</title>
		<imprint>
			<biblScope unit="volume">34</biblScope>
			<biblScope unit="page" from="755" to="768" />
			<date type="published" when="2011">2011</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b51">
	<analytic>
		<title level="a" type="main">Genetic loss of murine pyrin, the familial Mediterranean fever protein, increases interleukin-1beta levels</title>
		<author>
			<persName><forename type="first">P</forename><forename type="middle">R</forename><surname>Hesker</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Nguyen</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Kovarova</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">P</forename><surname>Ting</surname></persName>
		</author>
		<author>
			<persName><forename type="first">B</forename><forename type="middle">H</forename><surname>Koller</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">PLoS One</title>
		<imprint>
			<biblScope unit="volume">7</biblScope>
			<biblScope unit="page">e51105</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b52">
	<analytic>
		<title level="a" type="main">Pyogenic arthritis, pyoderma gangrenosum, and acne syndrome (PAPA syndrome) with E250K mutation in CD2BP1 gene treated with the tumor necrosis factor inhibitor adalimumab</title>
		<author>
			<persName><forename type="first">H</forename><surname>Lee</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">H</forename><surname>Park</surname></persName>
		</author>
		<author>
			<persName><forename type="first">S</forename><forename type="middle">K</forename><surname>Kim</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">Y</forename><surname>Choe</surname></persName>
		</author>
		<author>
			<persName><forename type="first">J</forename><forename type="middle">S</forename><surname>Park</surname></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">Clin Exp Rheumatol</title>
		<imprint>
			<biblScope unit="volume">30</biblScope>
			<biblScope unit="page">452</biblScope>
			<date type="published" when="2012">2012</date>
		</imprint>
	</monogr>
</biblStruct>

<biblStruct xml:id="b53">
	<analytic>
		<title level="a" type="main">Pyogenic arthritis, pyoderma gangrenosum, acne, and hidradenitis suppurativa (PAPASH): a new autoinflammatory syndrome associated with a novel mutation of the PSTPIP1 gene</title>
		<author>
			<persName><forename type="first">A</forename><forename type="middle">V</forename><surname>Marzano</surname></persName>
		</author>
		<author>
			<persName><forename type="first">V</forename><surname>Trevisan</surname></persName>
		</author>
		<author>
			<persName><forename type="first">M</forename><surname>Gattorno</surname></persName>
		</author>
		<author>
			<persName><forename type="first">I</forename><surname>Ceccherini</surname></persName>
		</author>
		<author>
			<persName><forename type="first">De</forename><surname>Simone</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename><surname>Crosti</surname></persName>
		</author>
		<author>
			<persName><forename type="first">C</forename></persName>
		</author>
	</analytic>
	<monogr>
		<title level="j">JAMA Dermatol</title>
		<imprint>
			<biblScope unit="volume">149</biblScope>
			<biblScope unit="page" from="762" to="764" />
			<date type="published" when="2013">2013</date>
		</imprint>
	</monogr>
</biblStruct>

				</listBibl>
			</div>
		</back>
	</text>
</TEI>
